EP3212629
Setin 2,4-dímínó-kínólín sem ný krabbameinslyf
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
26.10.2015EP published:
24.10.2018EP application number:
15837091.6
EP translation filed:
15.1.2019Grant published:
15.2.2019EPO information:
European Patent Register
Max expiry date:
25.10.2035Expiry date:
25.10.2026Next due date:
31.10.2026
Title:
SUBSTITUTED 2,4 DIAMINO-QUINOLINE AS NEW ANTICANCER AGENTS
Timeline
Today
26.10.2015EP application
24.10.2018EP Publication
15.1.2019Translation submitted
15.2.2019Registration published
25.10.2026Expires
Owner
Name:
Genoscience Pharma SASAddress:
10, rue d'Iena, 13006, Marseille, FR
Inventor
Name:
BASSISSI, FirasAddress:
Marseille, FR
Name:
BERET, AntoineAddress:
Marseille, FR
Name:
BRUN, SoniaAddress:
Aix-en-Provence, FR
Name:
COURCAMBECK, JérômeAddress:
Marseille, FR
Name:
DUBRAY, ClarisseAddress:
Saint-Herblain, FR
Name:
NICOLAS, GregoryAddress:
Cesson Sevigne, FR
Name:
HALFON, PhilippeAddress:
Marseille, FR
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201462073325 PDate:
31.10.2014Country:
US
Classification
Categories:
C07D 401/04, A61K 31/47, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 15.1.2019
Expires: 25.10.2019
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 5
Paid: 13.9.2019
Expires: 25.10.2020
Payer: Acumass
Number: 6
Paid: 15.9.2020
Expires: 25.10.2021
Payer: Acumass
Number: 7
Paid: 17.9.2021
Expires: 25.10.2022
Payer: Acumass
Number: 8
Paid: 15.9.2022
Expires: 25.10.2023
Payer: Acumass
Number: 9
Paid: 20.9.2023
Expires: 25.10.2024
Payer: Acumass
Number: 10
Paid: 29.10.2024
Expires: 25.10.2025
Payer: Renewr
Number: 11
Paid: 30.9.2025
Expires: 25.10.2026
Payer: Acumass